Scholarly publications and presentations by Rochester Regional Health's Research department authors.

Follow


Submissions from 2022

Link

5-1-2022          Harnessing the Proteome in COPD to Identify Individuals Vulnerable to Frequent Exacerbations, S Sethi, University at Buffalo, Matthew Morris, Rochester Regional Health, Spencer Richman, Rochester Regional Health, et al.

Link

5-1-2022          Identification of Novel Biomarkers for COPD Phenotypes by Large-Scale Proteomics Analysis with UHR-IonStar, S Sethi, University at Buffalo, X Zhu, University at Buffalo, S Shen, University at Buffalo, et al.

Link

5-2022          Probing the potential interactions between two protein vaccine candidates from Nontypeable Haemophilus influenzae, Grace McGinnity, Rochester Institute of Technology, Rochester, NY., Janai Perdue, Rochester Institute of Technology, Rochester, NY., Natalie Labbe, Rochester Institute of Technology, Rochester, NY., et al.

Link

5-1-2022          Proteomic Network Analysis of Bronchoalveolar Lavage Fluid in Ex-Smokers to Discover Implicated Protein Targets and Novel Drug Treatments for Chronic Obstructive Pulmonary Disease, Manoj J. Mammen, Department of Medicine, School of Medicine and Dentistry, University of Rochester, Rochester, NY 14642, USA., Chengjian Tu, Department of Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, NY 14260, USA., Matthew C. Morris, Rochester Regional Health, et al.

Link

3-1-2022          Interferon-γ promotes monocyte-mediated lung injury during influenza infection, Taylor Schmit, University of North Dakota, Grand Forks, ND; Kai Guo, University of Michigan, Ann Arbor, MI; and Michael E. Pichichero, Rochester Regional Health

Link

2-5-2022          Randomized Mechlorethamine/Chlormethine Induced Dermatitis Assessment Study (MIDAS) Establishes Benefit of Topical Triamcinolone 0.1% Ointment Cotreatment in Mycosis Fungoides, Carolina V. Alexander-Savino, Rochester Skin Lymphoma Medical Group, 6800 Pittsford Palmyra Rd, Suite 150, Fairport, NY, 14450, USA., Catherine G. Chung, Dermatology and Pathology, The Ohio State University, Columbus, OH, 43210, USA., Elaine S. Gilmore, Rochester Skin Lymphoma Medical Group, 6800 Pittsford Palmyra Rd, Suite 150, Fairport, NY, 14450, USA., et al.

Link

2-2-2022          Computational prediction of intracellular targets of wild-type or mutant vesicular stomatitis matrix protein, Matthew C. Morris, Rochester Regional Health, Thomas M. Russell, Thomas Gosnell School of Life Sciences, Rochester Institute of Technology, Rochester, NY, United States of America., Cole A. Lyman, Rochester Regional Health, et al.

Link

1-14-2022          High Fidelity Modeling of Pulse Dynamics Using Logic Networks, Cole A. Lyman, Rochester Regional Health, Matthew M. Morris, Rochester Regional Health, Spencer Richman, Rochester Regional Health, et al.

Link

1-14-2022          Leveraging Drug-Target Interaction Data for the Translation of Computational Models into Clinically Actionable Interventions, Spencer C. Richman, Rochester Regional Health, Cole A. Lyman, Rochester Regional Health, Matthew C. Morris, Rochester Regional Health, et al.

Submissions from 2021

Link

11-11-2021          Attractor Landscapes as a Model Selection Criterion in Data Poor Environments, Cole A. Lyman, Rochester Regional Health, Spencer Richman, Rochester Regional Health, Matthew C. Morris, Rochester Regional Health, et al.

Link

6-2021          Serum antibody levels to pneumococcal polysaccharides 22F, 33F, 19A and 6A that correlate with protection from colonization and acute otitis media in children, Ravinder Kaur, Rochester Regional Health; Minh Pham, Rochester Institute of Technology; and Michael Pichichero, Rochester Regional Health

Link

5-17-2021          Gulf War Illness Clinical Trials and Interventions Consortium (GWICTIC): A Collaborative Research Infrastructure for Intervention and Implementation, Amanpreet K. Cheema, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Fort Lauderdale, FL, Rebecca B. McNeil, RTI International, Research Triangle Park, NC, Travis Craddock, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Fort Lauderdale, FL, et al.

Link

5-14-2021          A Vaccine Candidate Case Study: Understanding Protein D Antibody Suppression by Omp26, Anna Kasper; Niaya Jackson; and Ravinder Kaur, Rochester Regional Health

Link

5-14-2021          Optimizing Production and Purification of Bacterial Outer Membrane Vesicles, Tyler Pugeda, Milena Dinu, Lea Michel, et al.

Link

4-1-2021          Nasopharyngeal Microbiome Analyses in Otitis-Prone and Otitis-Free Children, Lei Xu, Rochester Regional Health, Josh Earl, Drexel University College of Medicine, Peter Bajorski, Rochester Institute of Technology, et al.

Link

3-22-2021          Comparison of Specific In-vitro Virulence Gene Expression and Innate Host Response in Locally Invasive vs Colonizer Strains of Streptococcus Pneumoniae, Naoko Fuji, Rochester Regional Health; Michael E. Pichichero, Rochester Regional Health; and Ravinder Kaur, Rochester Regional Health

Link

3-2021          Can Machine Learning and AI Replace Otoscopy for Diagnosis of Otitis Media?, Michael E. Pichichero, Rochester Regional Health

Submissions from 2020

Link

12-1-2020          Ampicillin triggers the release of Pal in toxic vesicles from Escherichia coli, Lea Vacca Michel, Rochester Institute of Technology, Leslie Gallardo, Rochester Institute of Technology, Anna Konovalova, University of Texas Health Science Center at Houston, et al.

Link

10-1-2020          Hacking the Immune Response to Infection in Chronic Obstructive Pulmonary Disease, Matthew C. Morris, Rochester Regional Health, Spencer Richman, Rochester Regional Health, Cole A. Lyman, Rochester Regional Health, et al.

Link

10-1-2020          Predicting the Immune Response to Repurposed Drugs in Coronavirus-induced Cytokine Storm, Matthew C. Morris, Rochester Regional Health, Cole A. Lyman, Rochester Regional Health, Spencer Richman, Rochester Regional Health, et al.

Link

9-1-2020          Evaluation and management of patients with early-stage mycosis fungoides who interrupt or discontinue topical mechlorethamine gel because of dermatitis, Elaine S. Gilmore, Rochester Skin Lymphoma Medical Group, Carolina V. Alexander-Savino, Rochester Skin Lymphoma Medical Group, Catherine G. Chung, The Ohio State University, et al.

Link

9-1-2020          The VSV matrix protein inhibits NF-κB and the interferon response independently in mouse L929 cells, Kaitlin A. Marquis, Thomas H. Gosnell School of Life Sciences, Rochester Institute of Technology, Rochester, NY, 14623, USA., Rachel L. Becker, University of Colorado Denver, Anschutz Medical Campus, USA., Amanda N. Weiss, Thomas H. Gosnell School of Life Sciences, Rochester Institute of Technology, Rochester, NY, 14623, USA., et al.

Link

7-21-2020          Interaction of amphiphilic coumarin with DPPC/DPPS lipid bilayer: effects of concentration and alkyl tail length, Poornima Kalyanram, Rochester Institute of Technology, Huilin Ma, Shena Marshall, Rochester Institute of Technology, et al.

Link

6-11-2020          Immune Network Modeling Predicts Specific Nasopharyngeal and Peripheral Immune Dysregulation in Otitis-Prone Children, Matthew C. Morris, Rochester Regional Health, Timothy J. Chapman, Rochester Regional Health, Michael E. Pichichero, Rochester Regional Health, et al.

Link

6-9-2020          Comparison of anti-capsular antibody quantity and functionality in children after different primary dose and booster schedules of 13 valent-pneumococcal conjugate vaccine, Ravinder Kaur, Rochester Regional Health and Michael Pichichero, Rochester Regional Health